Pfizer Inc. (NYSE:PFE) is one of the best large cap value stocks to buy now. On September 23, Bank of America Securities analyst Tim Anderson maintained a neutral stance on Pfizer Inc. (NYSE:PFE), giving the stock a Hold rating with a $28 price target.
The analyst supported the rating with the company’s financial outlook and strategic moves, stating that Pfizer Inc.’s acquisition of Metsera is a notable and positive step in entering the obesity market.
However, Anderson added that the acquisition’s full potential is contingent on several pipeline-related milestones, and the deal is still subject to shareholder approval and other conditions.
Pfizer Inc. is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
